An innovative treatment for debilitating and often deadly cases of recurrent C diff infection has been given a Breakthrough Therapy Designation by the FDA. Developed by US biotech firm Rebiotix, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback